© 2004 American Public Health Association
Herbert L. Needleman is with the Departments of Psychiatry and Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pa. Philip J. Landrigan is with the Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, NY. Correspondence: Requests for reprints should be sent to Herbert L. Needleman, MD, Department of Psychiatry, Keystone Bldg, Suite 310, Pittsburgh, PA 15217 (e-mail: hlnlead@pitt.edu).
Bernard states that current knowledge does not warrant lowering the Centers for Disease Control and Preventions (CDCs) definition of pediatric lead intoxication below the current level of 10 µg/dL.1 Bernard cites, in support, economic considerations, inadequate health risk data, and limited options for intervention. As investigators of lead toxicity and pediatricians who have treated poisoned children, our position is that only health-based criteria are acceptable for setting a health standard. Costbenefit analyses and policy issues are peripheral and subordinate to the central question: What level of lead in blood is toxic for a child?
Over the past century, as knowledge This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||